Further Information
RSK, HU-1, RSK1, MAPKAPK1A, MEK3, MKK3, PRKMK3, SKK2, KS6A1, MAPKAP-K1a, RPS6KA1, S6K-alpha 1
Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200
Serine/threonine kinase that may play a role in mediating the growth-factor and stress induced activation of the transcription factor CREB.
- Silverman E, et al. Mol Cell Biol. 2004 Dec; 24 (24): 10573-10583. Andrew D, et al. Biochem J. 2006 February 1; 393 (Pt 3): 715?724. Itoh S, et al. J Biol Chem 2005 Jun 24; 280 (25): 24135-24142
Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
1 mg/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
p90RSK (Phospho-Thr348) antibody was raised against a peptide sequence around phosphorylation site of threonine 348 (S-R-T (p) -P-R) derived from Human p90RSK.
Phospho-Specific
6195
ribosomal protein S6 kinase, 90kDa, polypeptide 1
RPS6KA1
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
90 kDa
NP_001006666.1
55743134
Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.
Phospho-Specific,Apoptosis,Cancer,Cell Cycle
This antibody detects endogenous level of p90RSK only when phosphorylated at threonine 348.
Q15418